New classification system may help guide treatment for colorectal cancer spread to liver
NCT ID NCT07569341
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new classification system for people whose colorectal cancer has spread only to the liver. Researchers looked at survival rates and compared different patient groups to see if the system helps predict outcomes. The goal is to better identify which patients might benefit from surgery or other treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
116 people
The number who actually took part.
- Started
-
Nov 2021
- Finished
-
Apr 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
All patients with colorectal liver metastases assessed at multidisciplinary team conferences in Linköping University Hospital 2021-11-01 -- 2022-12-31
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria * Colorectal liver metastasis. * Discussed at a multidisciplinary tumor board Exclusion Criteria: * Age less than 18 years. * Previous cancer in the gastrointestinal tract * Ongoing oncological treatment for cancers other than gastrointestinal cancers
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Colorectal adenocarcinoma metastatic in the liver are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Linköping University Hospital
Linköping, Sweden
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Immunotherapy combo aims to turn inoperable liver tumors into operable ones
- Can targeted liver chemo turn inoperable tumors into operable ones?
- New blood test could spot colon cancer before it spreads
- New online tool aims to ease Cancer's toll on patients and loved ones
- Liver-Focused chemo after surgery aims to stop cancer return
- New drug combo aims to shrink liver tumors in colorectal cancer patients